Lin Xu

6.2k total citations
202 papers, 4.7k citations indexed

About

Lin Xu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Lin Xu has authored 202 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 62 papers in Cancer Research and 52 papers in Immunology. Recurrent topics in Lin Xu's work include MicroRNA in disease regulation (41 papers), Cancer-related molecular mechanisms research (28 papers) and Circular RNAs in diseases (25 papers). Lin Xu is often cited by papers focused on MicroRNA in disease regulation (41 papers), Cancer-related molecular mechanisms research (28 papers) and Circular RNAs in diseases (25 papers). Lin Xu collaborates with scholars based in China, United States and Canada. Lin Xu's co-authors include Ya Zhou, Zhenke Wen, Juanjuan Zhao, Mengmeng Guo, Cesar V. Borlongan, Giora Feuerstein, Sidong Xiong, Chao Chen, Wei Xu and Takao Yasuhara and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Lin Xu

196 papers receiving 4.6k citations

Peers

Lin Xu

IMMUN

ONCOL

SURGE

Ling Wu China

Pieter Koolwijk Netherlands

Rui Liu China

Xin Xie China

Ewa Paleolog United Kingdom

Anil K. Chauhan United States

Bénédicte Dubois Belgium

Matthias Friedrich Germany

Marco Marchisio Italy

Aurora Astudillo Spain

Ling Wu China

Lin Xu

2.2k ×1.0

1.5k ×1.3

IMMUN

663 ×0.6

1.3k ×1.9

ONCOL

387 ×0.7

SURGE

Citations per year, relative to Lin Xu Lin Xu (= 1×) peers Ling Wu

Countries citing papers authored by Lin Xu

Since Specialization

Citations

This map shows the geographic impact of Lin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xu more than expected).

Fields of papers citing papers by Lin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xu. The network helps show where Lin Xu may publish in the future.

Co-authorship network of co-authors of Lin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Xu. A scholar is included among the top collaborators of Lin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Xu. Lin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Yidan, et al.. (2025). A review of C/EBP α: a potential novel target for solid tumor intervention. Journal of Translational Medicine. 23(1). 894–894. 1 indexed citations

Zhu, Yiling, Jiayi Zhang, Xu Zhao, et al.. (2025). MicroRNA-7 as a multifaceted regulator of tumor glycolytic metabolism: Mechanistic insights and therapeutic perspectives. Pharmacological Research. 218. 107822–107822. 1 indexed citations

Gao, Zhen, Xiao Li, Lin Xu, et al.. (2024). Preoperative markers for identifying CT ≤2 cm solid nodules of lung adenocarcinoma based on image deep learning. Thoracic Cancer. 15(31). 2272–2282. 2 indexed citations

Xu, Lin, et al.. (2024). Patient-Reported Outcomes in Chinese Patients with Locally Advanced or Recurrent Colorectal Cancer After Pelvic Exenteration. Annals of Surgical Oncology. 31(12). 7783–7795. 1 indexed citations

Qiu, Hui, Nan Shao, Jing Liu, et al.. (2023). Amino acid metabolism in tumor: New shine in the fog?. Clinical Nutrition. 42(8). 1521–1530. 19 indexed citations

Chen, Chao, Mengmeng Guo, Xu Zhao, et al.. (2023). MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases. Biomolecules. 13(8). 1185–1185. 7 indexed citations

Zhang, Shuai, Zhiyun Xu, Gaochao Dong, Ming Li, & Lin Xu. (2021). Analysis of Clinical Characteristics of Lung Cancer Combined with  Multiple Primary Malignancies in Other Organs. SHILAP Revista de lepidopterología. 3 indexed citations

Wang, Xiaoju, et al.. (2020). Delicaflavone Reverses Cisplatin Resistance via Endoplasmic Reticulum Stress Signaling Pathway in Non-Small Cell Lung Cancer Cells. SHILAP Revista de lepidopterología. 1 indexed citations

Xu, Lin, et al.. (2020). Plasma cell-free DNA for screening patients with benefit-assisted neoadjuvant chemotherapy for advanced gastric cancer. ScienceAsia. 46(4). 462–462. 3 indexed citations

10.

Li, Peipei, et al.. (2020). Upregulated microRNA‐126 induces apoptosis of dental pulp stem cell via mediating PTEN‐regulated Akt activation. Journal of Clinical Laboratory Analysis. 35(2). e23624–e23624. 7 indexed citations

11.

Xu, Xiao, Lin Che, Lin Xu, et al.. (2020). Green preparation of anti-inflammation an injectable 3D porous hydrogel for speeding up deep second-degree scald wound healing. RSC Advances. 10(59). 36101–36110. 8 indexed citations

12.

Chen, Chao, Hairong Wang, Jia Lu, et al.. (2018). Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect. Molecular Therapy — Nucleic Acids. 11. 508–514. 48 indexed citations

13.

Cui, Panpan, Yan Hu, Yijing Tao, et al.. (2016). [miR-126 knockdown enhances the activity of murine CD4+ T cells in vivo and promotes their differentiation into Th1 cells].. PubMed. 32(3). 347–51. 4 indexed citations

14.

Xu, Lei, Xin Zhou, Mantang Qiu, et al.. (2013). Lack of Association between Hsa-miR-149 rs2292832 Polymorphism and Cancer Risk: A Meta-Analysis of 12 Studies. PLoS ONE. 8(9). e73762–e73762. 21 indexed citations

15.

Xu, Lin, et al.. (2009). Study of the effect of bone marrow cells from different grade of mice on the preparation of predominant DC2.. Journal of Tropical Medicine. 9(2). 164–167.

16.

Xu, Wei, et al.. (2007). An Anti-Double-Stranded DNA Monoclonal Antibody Induced by Tumor Cell–Derived DNA Inhibits the Growth of Tumor In Vitro and In Vivo via Triggering Apoptosis. DNA and Cell Biology. 27(2). 91–100. 9 indexed citations

17.

Yasuhara, Takao, Noriyuki Matsukawa, Koichi Hara, et al.. (2006). Transplantation of Human Neural Stem Cells Exerts Neuroprotection in a Rat Model of Parkinson's Disease. Journal of Neuroscience. 26(48). 12497–12511. 228 indexed citations

18.

Haughney, Peter C., John R. Lowe, Jeriza Rusit, et al.. (2005). Clinical Pharmacokinetics of Ranibizumab (LucentisTM) in Subjects With AMD. Investigative Ophthalmology & Visual Science. 46(13). 1383–1383. 7 indexed citations

19.

Xu, Lin, et al.. (2004). Cellular vacuolization induced by truncated large surface antigen of hepatitis B virus due to pregenomic RNA splicing. Zhonghua weishengwuxue he mianyixue zazhi. 24(4). 279–283. 1 indexed citations

20.

Fu, Lina, et al.. (1999). Ultrasonically Guided Inferior Vena Cava Stent Placement: Experience in 83 Cases. Journal of Vascular and Interventional Radiology. 10(1). 85–91. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact